BioSpace News Archive

Edwards Lifesciences (NYSE: EW), plans to announce its operating results for the quarter ended September 30, 2020 after the market closes on Wednesday, October 21, 2020 , and will host a conference call at 5:00 p.m. ET that day to discuss those results.

20/20 BioResponse, a business unit of 20/20 GeneSystems, Inc., announced today that it is now accepting orders for the Assure COVID-19 IgG/IgM Rapid Test kits. These kits were the first to receive an emergency use authorization (EUA) from the FDA for point-of-care (POC) use with fingerstick blood samples on Sep

American Bio Medica Corporation announced they have signed a distribution agreement with Co-Diagnostics, Inc. granting ABMC the right to market and sell the Logix Smart Covid-19 tests in the United States on a non-exclusive basis.